NASDAQ Gainers: Apple Inc. (NASDAQ:AAPL), Cesca Therapeutics Inc (NASDAQ:KOOL), Canadian Solar Inc. (NASDAQ:CSIQ), Cytokinetics, Inc. (NASDAQ:CYTK)

Apple Inc. (NASDAQ:AAPL) has long been a trend-setter whose hot products attract imitators, and now its recent stock split might help revive a trend from the 1990s that has all but disappeared on Wall Street. On Wednesday, the iPad maker and largest U.S. company by market value said it would do a seven-for-one split, knocking its share price down from the $500-plus level to something closer to $75. Apple Inc. (NASDAQ:AAPL) stock performance was 8.20% in last session and finished the day at $567.77. Traded volume was 27.14million shares in the last session and the average volume of the stock remained 10.60million shares. The beta of the stock remained 1.01. Apple Inc. (NASDAQ:AAPL) insider ownership is 0.04%.

Nano cap Cesca Therapeutics Inc (NASDAQ:KOOL) shows bullish price action with today’s up move on a 10x surge in volume. It represents a successful retest of the January 21 breakout when prices popped 111% on massive turnover of 32.9M shares after the company announced positive Phase 1b clinical trial results for its stem cell therapy for critical limb ischemia. Cesca Therapeutics Inc (NASDAQ:KOOL) rose 28.75 percent to $2.06 Thursday on volume of 9.41million shares. The intra-day range of the stock was $1.76 to $2.19. Cesca Therapeutics Inc (NASDAQ:KOOL) has a market capitalization of $67.18million.

Other stocks worth considering in the solar industry include Canadian Solar Inc. (NASDAQ:CSIQ), sporting a Zacks Rank #1 (Strong Buy). Canadian Solar Inc. (NASDAQ:CSIQ)’s stock on Apr 24, 2014 reported a increase of 5.10% to the closing price of $30.70. Its fifty two weeks range is $4.25 -$44.50. The total market capitalization recorded $1.66billion. The overall volume in the last trading session was 4.39million shares. In its share capital, CSIQ has 54.23million outstanding shares.

Cytokinetics, Inc. (NASDAQ:CYTK) announced that it is scheduled to report first quarter results on Tuesday, May 6, 2014 at 4:00 PM Eastern Time. Following the announcement, Cytokinetics Inc. (NASDAQ:CYTK)’s senior management will host a conference call at 4:30 PM Eastern Time to discuss operational and financial results and the company’s outlook for the future. On Thursday, shares of Cytokinetics, Inc. (NASDAQ:CYTK) advanced 8.98% to close the day at $12.99. Company return on investment (ROI) is -62.30% and its monthly performance is recorded as 44.65%. Cytokinetics, Inc. (NASDAQ:CYTK) quarterly revenue growth is 44.01%.